These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31930070)
1. Prognostic and clinicopathological significance of Wang Y; Wu Y; Li J; Lai Y; Zhou K; Che G Ann Transl Med; 2019 Nov; 7(22):669. PubMed ID: 31930070 [TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of Kwon D; Yun JY; Keam B; Kim YT; Jeon YK World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis. Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987 [TBL] [Abstract][Full Text] [Related]
4. Clinical Role of Excision Repair Cross-Complementing 1 Gene Expression in Resected Esophageal Squamous Cell Carcinoma: A Meta-Analysis. Wang Y; Li J; Shen C; Wu Y; Che G Dig Dis Sci; 2020 Aug; 65(8):2264-2271. PubMed ID: 31713119 [TBL] [Abstract][Full Text] [Related]
5. FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis. Jiang T; Gao G; Fan G; Li M; Zhou C Lung Cancer; 2015 Jan; 87(1):1-7. PubMed ID: 25433983 [TBL] [Abstract][Full Text] [Related]
6. Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma. Wang D; Du L; Wang Z; Liu X; Qin Y; Wang Q; Yang Z; Yao Z; Shi M; Shang B; Jia Y; Chen H; Qiao L; Wang X; Xiao Z; Liu Z Oncotarget; 2017 Oct; 8(51):88857-88869. PubMed ID: 29179482 [TBL] [Abstract][Full Text] [Related]
7. High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients. Song Q; Liu Y; Jiang D; Wang H; Huang J; Xu Y; Sujie A; Zeng H; Xu C; Hou Y Oncotarget; 2017 Sep; 8(43):74539-74553. PubMed ID: 29088806 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic role of MMP-9 in esophageal squamous cell carcinoma: a meta-analysis. Zeng R; Duan L; Kong Y; Liang Y; Wu X; Wei X; Yang K Chin J Cancer Res; 2013 Dec; 25(6):637-45. PubMed ID: 24385690 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis. Qu HX; Zhao LP; Zhan SH; Geng CX; Xu L; Xin YN; Jiang XJ J Thorac Dis; 2016 Nov; 8(11):3197-3204. PubMed ID: 28066599 [TBL] [Abstract][Full Text] [Related]
10. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients. Chen B; Liu S; Gan L; Wang J; Hu B; Xu H; Tong R; Yang H; Cristina I; Xue J; Hu X; Lu Y Cancer Biol Ther; 2018 Jan; 19(1):76-86. PubMed ID: 29257923 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis. Li C; Li Z; Zhu M; Zhao T; Chen L; Ji W; Chen H; Su C PLoS One; 2012; 7(9):e44764. PubMed ID: 23028610 [TBL] [Abstract][Full Text] [Related]
12. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients. Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214 [TBL] [Abstract][Full Text] [Related]
13. The CXCR4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis. Chen P; Zhang YL; Zhang XL; Guo Y; Tang PP Medicine (Baltimore); 2024 Apr; 103(14):e37681. PubMed ID: 38579048 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis. Ping W; Sun W; Zu Y; Chen W; Fu X Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106 [TBL] [Abstract][Full Text] [Related]
15. Wang X; Ge X; Wang H; Huang J; Song Q; Xu C; Jiang Z; Su J; Wang H; Tan L; Jiang D; Hou Y Ann Transl Med; 2021 Feb; 9(4):321. PubMed ID: 33708948 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Jung DH; Shin SK; Lee SK; Lee YC; Kim HR; Moon YW; Kim JH; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC Oncotarget; 2015 Feb; 6(4):2562-72. PubMed ID: 25537505 [TBL] [Abstract][Full Text] [Related]
17. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients. Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149 [TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological value of Ki-67 in patients with oesophageal squamous cell carcinoma: a systematic review and meta-analysis. Wang Y; Dai M; Chen X BMJ Open; 2024 Jun; 14(6):e083637. PubMed ID: 38839387 [TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk. Sun G; Hu W; Lu Y; Wang Y Pathol Oncol Res; 2013 Oct; 19(4):685-93. PubMed ID: 23658132 [TBL] [Abstract][Full Text] [Related]
20. The association of melanoma-associated antigen-A gene expression with clinicopathological characteristics and prognosis in resected non-small-cell lung cancer: a meta-analysis. Wang Y; Lu Y; Li J; Wu Y; Che G Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):855-860. PubMed ID: 31384932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]